Press releases
- Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers
- Hims & Hers Welcomes Anja Manuel, Foreign Policy Expert, Domestic Regulations Advisor, and Former Diplomat to its Board of Directors
- Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results
- Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024
- Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member
- Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024
More ▼
Key statistics
As of last trade Hims & Hers Health Inc (82W:FRA) traded at 18.50, -6.42% below its 52-week high of 19.77, set on May 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 18.25 |
---|---|
High | 18.50 |
Low | 17.75 |
Bid | 18.05 |
Offer | 18.77 |
Previous close | 18.05 |
Average volume | 35.03k |
---|---|
Shares outstanding | 214.79m |
Free float | 178.55m |
P/E (TTM) | -- |
Market cap | 4.17bn USD |
EPS (TTM) | -0.0145 USD |
Data delayed at least 15 minutes, as of Jun 03 2024 13:29 BST.
More ▼